Aortic Vascular Calcification: Cholesterol Lowering Does Not Reduce Progression in Patients With Familial Hypercholesterolemia-or Does It?

Rajamannan, Nalini M; Nattel, Stanley

Rajamannan, Nalini M; Nattel, Stanley.

Afiliación

Rajamannan NM; Division of Cardiology, Most Sacred Heart of Jesus Cardiology and Valvular Institute, Sheboygan, WI; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN. Electronic address: nrajamannan@gmail.com.
Nattel S; Department of Medicine, Montreal Heart Institute and Université de Montréal, Montréal, Canada; Department of Pharmacology and Therapeutics, McGill University, Montreal, Canada; Institute of Pharmacology, West German Heart and Vascular Center, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.

Can J Cardiol ; 33(5): 594-596, 2017 05.

Article en En | MEDLINE | ID: mdl-28449831

Asunto(s)

Hiperlipoproteinemia Tipo II; Calcificación Vascular; Aorta; Colesterol; Humanos; Hipercolesterolemia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calcificación Vascular / Hiperlipoproteinemia Tipo II Límite: Humans Idioma: En Revista: Can J Cardiol Asunto de la revista: CARDIOLOGIA Año: 2017 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google